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At birth water is rapidly reabsorbed from the distal lung in
preparation for alveolar gas exchange. To investigate a po-
tential role for the AQP1 water channel in development,
lung membranes from fetal and perinatal rats were ana-
lyzed by immunoblot. First expression of AQP1 was noted
in fetal rat lung at E19 (19th day of the 21-day gestation).
The level of AQP1 increased fivefold from the last gesta-
tional day to the first postnatal day and persisted at high
levels into adulthood. Maternal corticosteroids increased ex-
pression of AQP1 in fetal lung, an effect also seen in adult
rats. AQP1 mRNA increased in rat pups treated with corti-
costeroids, suggesting at least partial regulation at the level
of transcription. Immunohistochemical analyses with anti-
AQP1 demonstrated the protein in peribronchial vessels
and visceral pleura at E21 with increased postnatal expres-
sion. AQP1 was not expressed in airway epithelium, and
only occasional alveolar pneumocytes were labeled. Immu-
noelectron microscopy revealed AQP1 on both apical and
basolateral membranes of endothelial cells. The ontogeny
and corticosteroid induction of AQP1 in rat lung coincide
with major physiological alterations in lung development;
however, the distribution of AQP1 predicts the existence of


























The lung undergoes a remarkable functional transition at the
time of birth, and physiological aspects of perinatal lung fluid
balance have been extensively studied. Fluid is secreted into
the airways throughout much of gestation; lung fluid content is
thought to be important for normal lung development (1).
Near parturition, lung fluid secretion stops and accumulated
water is reabsorbed from the airspaces as the lung prepares to
assume responsibility for gas exchange (2). The first step of
lung water clearance at birth is movement of fluid from the
lung lumen into the interstitium, a process believed to be
driven by sodium transport across the alveolar epithelium (2).
The sodium channel antagonist amiloride blocked induction of
lung water reabsorption by epinephrine (3) and dibutyryl
cAMP (4); instillation of amiloride down the trachea of neona-
tal guinea pigs caused hypoxemia and increased extravascular
lung water (5). Both fetal (6) and adult (7) type II pneu-
mocytes in culture exhibit amiloride-sensitive sodium reab-
sorption. Fewer details are known about the second step in
perinatal lung water clearance — removal of fluid from the in-
terstitium — though it appears that the predominant pathway
for clearance is the circulation rather than the lymphatics (8). 
While understanding of the physiology and salt transport
pathways of fetal lung development is steadily increasing, the
molecular basis for water reabsorption in the perinatal lung re-




 is the first character-
ized member of a family of proteins which form water-specific
channels (9). AQP1 is expressed in several secretory and ab-
sorptive epithelia, as well as capillary endothelia in many or-
gans including lung (10, 11). Developmental expression of
AQP1 is complex, and tissue-specific patterns have been de-




) Prenatal expression of AQP1 occurs in
some tissues at the time of first physiological need with down-
regulation of the mRNA after birth; e.g., expression in cornea





curs in other tissues throughout prenatal and postnatal life;
e.g., expression in the choroid plexus is apparently linked to




) Expression is predomi-
nantly postnatal in still other tissues; e.g., expression in the
proximal nephron closely precedes the ability of the kidneys to
conserve water, as needed for survival after weaning, while ex-
pression in red cells is thought to enhance their survival as they
transit the hypertonic renal medulla. The studies of fetal rat
kidney and red cells were found to be relevant to human de-
velopmental expression patterns (14). 
The roles which aquaporins play in the pathogenesis of sev-
eral disease states are beginning to emerge (15). Mutations in
the renal collecting duct homolog AQP2 are responsible for
some forms of nephrogenic diabetes insipidus in humans (16).
Mutations in the lens aquaporin MIP (major intrinsic protein)
are known to underlie at least one form of congenital cataract
in mice (17, 18). Worldwide blood group referencing has iden-
tified extremely few individuals totally lacking the Colton
Blood group antigen. Three Colton-null individuals were





but surprisingly none suffered any apparent clinical conse-
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quence (19). Although no evidence has yet demonstrated that
AQP1 may be the rate-limiting factor in pulmonary water





 suggests that these individuals may express
some compensating factor (19). Since pulmonary dysfunction
is a known source of morbidity for premature human infants
(20), this study was undertaken to determine the developmen-
tal expression, potential hormonal modulation, and distribu-
tion of AQP1 in rat lung, in order to evaluate a possible role in







Polyclonal, affinity-purified rabbit antibodies to AQP1
(anti-AQP1), which react with the 4 kD carboxy-terminal domain of
the protein (21), and affinity-purified rabbit antibodies to red cell





was the kind gift of Dr. Susan Craig. Electrophoresis reagents were









P]-dCTP for Northern blots were from Amersham
Corp. (Arlington Heights, IL). Molecular biologic enzymes and re-
agents were from GIBCO BRL (Gaithersburg, MD). RNAzol B for
RNA isolation was from Tel-Test, Inc. (Friendswood, TX). Be-
tamethasone was from Schering Corp. (Kenilworth, NJ). BCA Pro-
tein Assay was from Pierce (Rockford, IL). Other reagents and sup-
plies were from Sigma Immunochemicals (St. Louis, MO), J. T. Baker




Sprague-Dawley rats (Harlan Sprague-Daw-
ley, Indianapolis, IN) were used in the following series of experi-
ments in which tissues were harvested for protein immunoblots or
Northern blot analysis. All animal studies were undertaken with pro-
tocols approved by the Johns Hopkins School of Medicine Animal





) Lungs were harvested from fetal rats on embryonic day 16
(E16) through E21 (21-d-term), from postnatal rats 1, 2, 4, 8, and 15 d




















15), and from adult rats (A).





) Newborn pups from separate litters were killed at specific in-






) Pregnant rats were injected intramuscularly with either be-
tamethasone (0.35 mg/kg) or 0.9% NaCl (control; 0.02 ml). Rats were
injected on two consecutive days, and killed on the third day, which is
the age reported. Lungs were isolated from control and steroid-




1), as well as from














forepaws from E21 fetal rats were isolated after injection of either














7) received a single injection of either 0.9%
NaCl (0.02 ml) or betamethasone (0.35 mg/kg), and were killed at
baseline, 12, and 24 h after injection. Lungs were harvested for pro-
tein immunoblots or Northern blot analysis. Rats from a single litter




Timed pregnant or adult Sprague-Dawley
rats were used in all studies. Animals were allowed free access to
food and water until death. 




 and decapitated; fetal rats
were decapitated after killing of the mother. The thorax was opened,
and the lungs perfused through the right ventricle and pulmonary ar-
tery with chilled 5 mM sodium phosphate (pH 8.0), 150 mM NaCl,
1mM EDTA (PBS-EDTA) until free of blood. Perfusion of fetal rats
was accomplished with 25-gauge needles. Rats used for harvest of
kidneys were perfused through both the right and left ventricle until








C for subsequent isolation of membranes or RNA (see below).
Lungs from fetal rats and 1-d-old rat pups were pooled by litter in or-
der to have adequate sample for processing; specimens from older an-




Tissues were homogenized in a
Potter-Elvehjem homogenizer on ice in buffer containing 0.25M su-
crose with protease inhibitors 1 mM phenylmethylsulfonyl fluoride,









) centrifugation of the homo-




) centrifugation of the su-
pernatant. Membrane pellets were solubilized in 1.5% SDS (wt/vol),
and total protein concentration was measured spectrophotometri-
cally with the BCA Protein Assay (Pierce), using bovine serum albu-
min as the standard. 
 
Red blood cell membrane preparation.
 
RBC membranes from both




1) rats were prepared by five cycles of hypo-
tonic lysis in 5 mM sodium phosphate with the above-listed protease









SDS-PAGE was performed using








6 cm 12% acryl-




g total membrane protein was loaded for each
sample; SDS-PAGE gels were stained with Coomassie brilliant blue
(Bio-Rad) to confirm equivalence of samples. Immunoblotting was
performed as described (24), using enhanced chemiluminescence and
autoradiography to visualize immunoblots. Contact prints of autora-




RNA was isolated from rat lungs using RNAzol
B solution (Tel-Test, Inc., Friendswood, TX). RNA concentrations
were assessed spectrophotometrically, and confirmed with formalde-




g total RNA per sample was resolved on a
formaldehyde agarose gel, and transferred to nitrocellulose. Hybrid-
ization was performed at high stringency with full length mouse




P]dCTP as described (25). Blots were
visualized by autoradiography. 18S ribosomal RNA was visualized by
ultraviolet exposure of the nitrocellulose blot (Eagle Eye Systems;
Stratagene, La Jolla, CA). 
 
Preparation of tissues for immunocytochemistry.
 
Male Wistar rats
(postnatal day 1, 14, or 40) were anesthetized, heparinized, and perfu-
sion fixed through the right atrium with 8% paraformaldehyde in
0.1 M sodium cacodylate buffer (pH 7.2). Lungs of fetal pups at em-
bryonic days 15 and 21 (E15, E21) from heparinized, anesthetized
pregnant rats were immersion-fixed. Tissue blocks from adult rat lung
were postfixed in the same fixative for 2 h, infiltrated for 30 min with
2.3 M sucrose containing 2% paraformaldehyde, mounted on holders
and rapidly frozen in liquid nitrogen. These blocks were used for




The frozen samples were freeze-sub-
stituted (26, 27) in a Reichert AFS (Reichert, Vienna, Austria) or in
Balzers freeze-substitution unit (FSU 010, Balzers AG, Liechten-
stein). Samples were sequentially equilibrated over 3 d in 0.5% ura-




































C the samples were serially infiltrated with Lowicryl
HM 20 and methanol 1:1, 2:1 and finally pure HM20, before UV-poly-

















microscopic observations paraffin sections were placed on gelatin
coated glass slides, and endogenous peroxidase activity (exclusively









75% methanol, followed by extensive wash in PBS. After preincuba-
tion with PBS containing 1% BSA and 0.05 M glycine, sections were




g/ml), and visualized with HRP-
conjugated secondary antibody. Sections were counter-stained with
Meier counter-stain. For electron microscopy immunolabeling was
performed on ultrathin Lowicryl sections (40–60 nm) or ultrathin cryo-
sections (80 nm) obtained on a Reichert Ultracut FSC ultracryomi-
 




crotome. The sections were incubated with anti-AQP1 and labeling
was visualized with goat anti–rabbit gold (10 nm). The sections were




The following controls were performed




) incubation with pro-

















) incubation without primary
antibody or without primary and secondary antibody. All controls re-









) was quantitated by densitometric scanning of auto-
radiographs with an UltroScan XL laser densitometer (Pharmacia
LKB Biotechnology Inc., Piscataway, NJ). The AQP1 signal on













standard error of the mean (SEM) for each
group. The effect of corticosteroids at multiple gestational ages was
assessed by two factor ANOVA (treatment, time). Assessment of ste-














Developmental expression of aquaporin-1 in rat lung.
 
Lung mem-
branes of fetal rats from embryonic day 16 (E16) through E21





through adult, were examined by anti-AQP1 immunoblot (Fig.
1). Equivalent lung membrane sample loadings were con-




). As a positive con-
trol, red blood cell (RBC) membranes demonstrated the 28-kD
AQP1 subunit and the 40–60-kD glycosylated AQP1 subunit




) (23). AQP1 was expressed in fetal




); rarely, AQP1 was found in fe-
tal lung samples at E17 or E18. AQP1 in lung increased four-
to fivefold from E20 to E21 (densitometric analysis, data not










1 was followed by a slower increase over the first two
weeks of postnatal life. AQP1 expression was sustained at high
levels in adult rat lung. AQP1 is substoichiometrically glycosy-
lated (21), but gly-AQP1 was not visible prior to postnatal day





membrane-associated protein (28), was present in lung mem-




). Spectrin was not present in
lung membranes at any age by immunoblot, confirming the
lack of RBC contamination (data not shown). 
To confirm that lung AQP1 was markedly increasing at
















brane samples from the two groups were similar, but the im-




1 rat pups by approximately fivefold compared with E21 fe-














 .05). To examine the rate of
increase during the day after birth, lungs were harvested at in-
tervals over the first 24 h after parturition. The immunoblot of















Figure 1. Anti-AQP1 immunoblots of rat lung membranes from em-
bryonic day 16 (E16) to adult (A). 12–15 mg total membrane protein 
were electrophoresed into 12% SDS-PAGE slabs and stained with 
Coomassie blue or immunoblotted with affinity-purified anti-AQP1 
antibody (see Methods). Adult rat red blood cell membranes (RBC) 
were included as a positive control. The stripped blot was incubated 
with antiserum raised to a-actinin. 
Figure 2. AQP1 expression in perinatal rat lung. (A) Lung mem-
branes were prepared from pooled litters of rats from embryonic day 
21 (E21) or postnatal day 1 (11) for SDS-PAGE and immunoblot. 
Each lane represents pooled membranes from a separate litter. Im-
munoblots were analyzed by densitometry, and the results expressed 
in arbitrary absorption units (A.U.) as mean6SEM for each age (P ,  
.05). (B) Lung membranes were prepared from rat pups of a single lit-
ter at the times noted after birth. Immunoblots from three separate 
litters were compared by densitometry, and the results combined for 








) demonstrates that AQP1 in rat lung doubled over the
first 7–9 h after birth (NS), and was threefold greater than






 .05). Five litters of fetal rats age E19-E21
were divided by gender, but no differences in AQP1 expres-
sion were noted (data not shown).
 
Effect of corticosteroids on aquaporin-1 expression.
 
Steroid
effects on expression of AQP1 in lung were assessed by immu-
noblotting lung membranes from fetal rats of mothers injected
with either corticosteroids or saline. Representative immuno-
blots of lung membranes from control and steroid-treated E18
and E21 fetal rats (
 
n  5  3 litters in each group) are shown (Fig.
3 A, top). Densitometry of a series of immunoblots demon-
strated that maternal corticosteroid administration increased
the expression of AQP1 in the fetal lungs (Fig. 3 A, bottom; n 5
3 litters per group except E16 (n 5 2); P ,  .001). To deter-
mine if corticosteroid induction of AQP1 in the lung was lim-
ited to fetal animals, lung membranes from control and ste-
roid-treated pregnant adult rats were immunoblotted with
anti-AQP1 (Fig. 3 B; n 5 5 each group). AQP1 expression was
increased sixfold in steroid-treated adult rats compared with
controls (Fig. 3 B, bottom; P ,  .001). 
To determine if corticosteroid-induction of AQP1 was glo-
bal or tissue-specific, steroid effects were assessed in nonpul-
monary tissues. AQP1 is abundant in renal proximal tubule,
where it is first expressed shortly before birth (13). Immuno-
blots of membranes from whole kidney of 14 and adult rats
treated with 0.9% NaCl or betamethasone revealed approxi-
mately twofold induction of AQP1 by corticosteroids in 4-d-old
rats (P ,  .05), but no induction in adult rats (NS; Fig. 4, A and
Figure 3. AQP1 expression in fetal and adult rat lung after cortico-
steroid administration. Pregnant rats were injected on successive days 
with physiological saline (0.02 ml) or betamethasone (0.35 mg/kg), 
and both fetal and adult lungs were harvested on a third day. Lung 
membranes were analyzed by SDS-PAGE and immunoblot. (A) 
Representative immunoblots from fetal lung membranes on embry-
onic days 18 (E18) and 21 (E21) are shown. Immunoblots from em-
bryonic day 16 to postnatal day 1 were compared by densitometry 
and expressed in arbitrary absorption units (A.U.) as mean6range 
(P  ,  .001 for steroid effects). (B) Immunoblot of control and ste-
roid-treated adult rat lung membranes with densitometric analysis ex-
pressed as mean6SEM (P ,  .001).
Figure 4. Effects of corticosteroid administration on AQP1 expres-
sion in rat extrapulmonary tissues. Rats were injected with two daily 
injections of either physiological saline (0.02 ml; control) or be-
tamethasone (0.35 mg/kg), and tissues harvested at the designated 
ages. (A) Kidney membranes from 4-d-old and adult rats were ana-
lyzed by SDS-PAGE and immunoblot. (B) RBC membranes from 
adult rat red cells and control (C) or steroid-treated (S) postnatal day 
1 (11) animals were analyzed by SDS-PAGE and immunoblot. The 
blot was then stripped, and reprobed with anti-spectrin to confirm 
equivalence of membrane loading. (C) Immunoblot of forepaws from 
E21 fetuses. (D) Densitometric analysis of immunoblots from A–C 
expressed in arbitrary absorption units as mean6SEM with control 
set at 100% (4 d kidney P , .05; others NS).
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D). RBCs contain abundant AQP1 (21, 29), but not until after
birth in the rat (13). RBC membranes were prepared from 11
rat pups of mothers injected with corticosteroids or saline.
Equivalent sample loadings were confirmed by Coomassie
staining or immunoblotting with anti-spectrin (Fig. 4 B, top,
bottom). Immunoblotting demonstrated that AQP1 was not
increased in RBCs from the steroid-treated animals (Fig. 4 B,
middle and 4 D). In addition, expression of AQP1 message in
long bones such as the forepaw has previously been demon-
strated (12). Forepaws were harvested from control and ste-
roid-treated E21 fetal rats, but steroid-induction of AQP1 ex-
pression was not observed (Fig. 4, C and D; NS).
To explore potential mechanisms of AQP1 induction by
corticosteroids, 7-d-old rat pups received a single injection of
saline or betamethasone, and lungs were harvested at baseline,
12 h, and 24 h after injection for isolation of membranes or
RNA for Northern analysis (Fig. 5 A). 12 h after injection,
AQP1 message was increased in steroid-treated rats by three-
fold over control (P ,  .05); 24 h after injection AQP1 message
levels were again similar in the two groups (NS; Fig. 5, A and
B). AQP1 protein expression was assessed by immunoblotting
lung membranes from the two groups (Fig. 5 C). Densitometry
of the immunoblots revealed that lung AQP1 protein levels
were not different 12 h after injection (NS), but steroid-treated
animals had 50% more AQP1 in lung than controls at 24 h (P ,
.05; Fig. 5 D). 
Distribution of AQP1 in developing rat lung. AQP1 distri-
bution was assessed by immunohistochemical analysis of fetal
(E15 and E21) and postnatal (1, 14, and 40 d old) rat lung (Fig.
6). AQP1 staining was absent from rat lung at E15 (Fig. 6 a),
but was strongly present in choroid plexus of the same fetuses
(Fig. 6 b). Preadsorption controls were negative in E15 chor-
oid plexus (Fig. 6 c) and 1-d-old lung (Fig. 6 i). At E21, visceral
pleura exhibited strong labeling for AQP1 (Fig. 6 d), as did
peribronchial capillaries (Fig. 6 e), similar to that seen in
peribiliary capillaries and biliary ductules (Fig. 6 f) and intra-
cardiac vessels (Fig. 6 g) at E21. By postnatal day 1, AQP1 was
more abundant in both visceral pleura (Fig. 6 h) and peribron-
chiolar capillaries (Fig. 6 j); occasional alveolar pneumocytes
were labeled. On postnatal day 14 AQP1 expression in venules
as well as peribronchiolar vessels was noted, with increased la-
beling of scattered alveolar epithelial cells (Fig. 6 k). At post-
natal day 40, abundant labeling of interstitial peribronchiolar
capillaries was evident; capillaries in the submucosal space
were also labeled. Bronchiolar epithelium was consistently un-
labeled (Fig. 6 l).
Immunoelectron microscopic evaluation of AQP1 distribu-
tion in rat lung confirmed the observations made by immuno-
histochemistry. AQP1 was demonstrated in both the apical
and basal plasma membrane of peribronchiolar capillary en-
dothelial cells (EN; Fig. 7, a and b). AQP1 was not detected in
capillary endothelial cells of the thin (EN; Fig. 7 c) or thick
(data not shown) portions of the alveolus. Epithelial cells, in-
cluding type II (Fig. 7 b, lower left) and type I (EP; Fig. 7 c)
pneumocytes did not exhibit AQP1 labeling by electron mi-
croscopy in the rat. 
Discussion
The understanding of perinatal lung development will remain
incomplete until the molecules determining the major trans-
port pathways are defined. Our studies of fetal rat lung docu-
ment that AQP1 expression first appears late in gestation, in-
creases prior to birth, and is sustained at high levels in adult
animals. The specific appearance of AQP1 in lung at E19 and
the severalfold increase from E20 to the first postnatal day
parallels the transition from secretion to absorption in the de-
veloping lung (2). Moreover, the ontogeny of AQP1 in fetal
lung is remarkably similar to that of the sodium channel,
arENaC (30), and the sodium pump, Na1K1-ATPase (31,
32). Although it seems unlikely that expression of AQP1 is
rate-limiting for perinatal lung water clearance, our studies are
consistent with participation of AQP1 in that process.
Administration of corticosteroids will improve pulmonary
functions in premature human infants, although the rationale
is still largely empirical (33). Our studies revealed that corti-
Figure 5. AQP1 expression in rat pup lung after 
corticosteroid administration. 7-d-old rat pups 
were injected intramuscularly with physiologi-
cal saline (0.02 ml) or betamethasone (0.35 mg/
kg); lungs were harvested before, 12, or 24 h af-
ter injection for preparation of lung membranes 
or isolation of total RNA. Rats from a single lit-
ter were used for each time point in order to 
control for inter-litter variability. (A) 10 mg total 
RNA from control and steroid-treated rat lungs 
was electrophoresed into a formaldehyde aga-
rose gel, transferred to nitrocellulose, and 
probed with full length mouse AQP1 cDNA la-
beled with [a-32P]dCTP. 18S ribosomal RNA vi-
sualized on the nitrocellulose by UV light is 
shown below. (Preinjection data not shown). (B) 
AQP1 signal on the Northern blot was quanti-
tated by Phosphorimager; results are expressed 
in arbitrary absorption units (A.U.) as 
mean6SEM (12 h P ,  .05; 24 h NS). (C) Lung 
membranes were analyzed by SDS-PAGE and 
immunoblot. (D) Immunoblots were analyzed 
by densitometry; results are expressed as in B 
(12 h NS; 24 h P ,  .05 compared with baseline).
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Figure 6. Immunohistochemical localization of AQP1 in rat lung and other tissues at embryonic days E15 (a–c), E21 (d–g), postnatal days 11 
(h–j), 114 (k) and 140 (l). Paraffin sections were incubated with anti-AQP1; immunolabeling controls in c and i were incubated with anti-AQP1 
preadsorbed with purified AQP1. (a–c) At E15, virtually no labeling was observed in lung (a), while choroid plexus was abundantly labeled (b); 
choroid plexus control was negative (c). (d–g) At E21 mesothelium of visceral pleura was strongly labeled (d, arrows), as was a peribronchial 
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costeroids increased the level of AQP1 expression in lung.
This effect appears to be tissue-specific, since corticosteroids
produced only a low-level induction of AQP1 in 4-d-old rat
kidney and had no effect in adult kidney, red cells, and devel-
oping long bone in forepaw. Of note, it has recently been dem-
onstrated that AQP2 is induced by corticosteroids in perinatal
but not adult kidney (34). Corticosteroid induction of AQP1 in
lung is consistent with other observations suggesting hormonal
modulation of lung development. Triiodothyronine and corti-
sol accelerate lung water clearance in thyroidectomized sheep
(35, 36) and accelerate expression of sodium channels in fetal
rat lung (30). Surfactant proteins, integral to the function and
homeostasis of the surfactant system, have a very similar on-
togeny in lung to AQP1 (37). In contrast to AQP1, gender-
specific differences in surfactant phospholipid expression have
been demonstrated in fetal animals (38), though it is less clear
that fetal surfactant protein expression is gender-dependent
(39). While their regulation is likely complex, surfactant pro-
teins are induced in both fetal (37, 39) and adult animals (40)
by corticosteroids. The dose of corticosteroids used in our
studies (0.35 mg betamethasone/kg) is approximately twice the
dose used clinically for premature labor in many hospitals. In-
terestingly, administration of 1.0 mg/kg betamethasone will in-
duce surfactant proteins (39), but did not induce AQP1 ex-
pression in fetal lung at E19 or E21 (data not shown). Since
therapeutic windows for induction of AQP1, surfactant phos-
pholipids and proteins, and sodium channels may be distinct,
definition of the corticosteroid response patterns may permit
design of improved therapies for the premature infant.
The effect of corticosteroids on expression of AQP1 in lung
was not limited to the fetal period. Steroid-treated pregnant
rats exhibited a sixfold increase in lung AQP1 over saline-
treated controls. The increase in AQP1 mRNA in lung follow-
ing corticosteroid administration suggests that at least partial
regulation of steroid-induced AQP1 expression is at the level
of transcription, and a functional glucocorticoid response ele-
ment (GRE) has recently been identified in the AQP1 pro-
moter (Moon, King, and Agre, unpublished observations). It
remains to be established if some of the known beneficial ef-
fects of corticosteroids in certain pulmonary disorders of
adults may be explained by the induction of AQP1. 
Our studies demonstrated that AQP1 was present in peri-
bronchial vasculature and visceral pleura of rat lung at E21,
and expression was further increased postnatally. No AQP1
expression was observed in airway epithelium, and only occa-
sional alveolar pneumocytes were labeled. The first step of
perinatal lung water clearance is thought to be across the epi-
thelial barrier into the interstitium. The minimal or absent ex-
pression of AQP1 in most alveolar epithelium predicts that
other pathways must reside at that location, and the existence
of AQP5 in the alveolar type I pneumocytes has been identi-
fied (41).
 At birth, fluid has been shown to collect in the peribron-
chiolar interstitial space before reabsorption into the circula-
tion (8, 42). When filtered through pulmonary microvascula-
ture or after crossing alveolar membranes, fluid moves from a
low compliance peripheral compartment into the high compli-
ance peribronchiolar interstitium (43) where the extensive vas-
cular plexus of the bronchial circulation (44) is believed to me-
diate clearance of interstitial edema (45, 46). Abundance of
AQP1 in peribronchiolar vessels may suggest a role in clear-
ance of water from the interstitial space. Fluid collects in the
peribronchiolar interstitial space before extending into alveoli
in models of pulmonary edema (47), a phenomenon which
may in part be mediated by AQP1 in those vessels. Similarly,
the presence of AQP1 in the visceral pleura may suggest par-
ticipation in the generation or absorption of pleural fluid or ef-
fusions. 
Immunoelectron microscopy revealed that AQP1 was ex-
pressed on both luminal and basolateral membranes of endo-
thelial cells. While it is attractive to postulate transcellular
movement of water through AQP1 in the lung, the role of wa-
ter channels in lung endothelium (and mesothelium) may not
be so straightforward. The predominant model of endothelial
permeability suggests that water movement across the mem-
brane occurs by a paracellular path under the influence of
Starling forces with large pores mediating clearance of water
and solute (48). The lung is not believed to have standing os-
motic gradients as a driving force for water channels, and ex-
periments demonstrating the presence of AQP1 and Hg-inhib-
itable water movement across descending vasa recta of the
kidney (49) and peritoneum (50) may not be directly analo-
gous to the lung. HgCl2 has been shown to inhibit water move-
ment into the alveolar space of an in situ perfused sheep lung
following instillation of hypertonic solution into the airway
(51). Although this was interpreted as representing the func-
tion of water channels at an undefined anatomic level between
blood and alveolus (51), toxicity of HgCl2 remains a possible
issue. AQP1 is enriched in caveolae-containing fractions of
lung endothelium, and Hg-inhibitable movement of water
across pulmonary vessels into the interstitium has recently
been described (52). Despite these suggestions, it remains pos-
sible that AQP1 is a principal participant in volume regulation
in lung endothelial cells rather than a mechanism for transcel-
lular water movement. Epithelial (53) and endothelial cells
(54) have been noted to change volume in response to a vari-
ety of stimuli, and changes in cell shape and volume may par-
ticipate in regulation of paracellular channels in endothelium.
While the ontogeny, steroid-responsiveness, and distribu-
tion of AQP1 in rat lung suggest a role for AQP1 in perinatal
lung water clearance and portend function in later life, the ab-
sence of AQP1 in alveolar epithelium predicts existence of an-
other water channel in that location. Nevertheless, dynamic
regulation of AQP1 expression in lung by endogenous mecha-
nisms may prove central to both normal physiology and
pathophysiology, and may ultimately provide a target for phar-
macologic manipulation of lung water permeability both in
prematurity and other pulmonary disorders. 
capillary plexus (e, arrows), while bronchial epithelium was unlabeled (E). Abundant AQP1 labeling was seen in peribiliary capillaries and biliary 
ductules (f), and capillaries and postcapillary venules in heart (g). (h–j) At postnatal day 11, strong labeling of pleura and periobronchiolar capil-
laries (arrows) was seen; rare pneumocytes were labeled. (k) At day 114, increased labeling was observed in peribronchiolar capillaries and 
larger venules; occasional pneumocytes were distinctly labeled. (l) At day 140, a capillary plexus external to the bronchiolar smooth muscle 
layer was strongly labeled, with less prominent submucosal labeling; bronchiolar epithelium was unlabeled. (a and c) 3100; (b, g–l) 3500; (d–f) 
3250.
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